Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Although many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, syringes are still the most widely used device to inject insulin. Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.
The U.S. insulin syringe market can be segmented by syringe type, yielding two segments: conventional insulin syringes and safety insulin syringes. In 2016, the largest segment in the total insulin syringe market was the conventional insulin syringe segment. Although conventional insulin syringes were once a popular method of insulin delivery, patients are transitioning towards new technologies such as insulin pens and pumps. Unit sales will continue to decline over the forecast period in conjunction with the growing penetration rate of insulin pens, as well as the growing penetration rate of insulin pumps among the type 2 insulin-dependent patient population. Mild ASP depreciation will also contribute to erosion in the value of the conventional insulin syringe market.
'
TABLE OF CONTENTS I
LIST OF FIGURES III
LIST OF CHARTS IV
EXECUTIVE SUMMARY 1
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 INTRODUCTION 26
2.1.1 Types of Diabetes 26
2.1.2 Diabetes Complications 28
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 30
2.1.4 Signs and Symptoms 31
2.1.5 Diabetes Monitoring 33
2.1.6 Treatment 35
2.1.7 Drug Delivery Systems 36
INSULIN SYRINGE MARKET 38
3.1 INTRODUCTION 38
3.2 MARKET OVERVIEW 39
3.3 MARKET ANALYSIS AND FORECAST 43
3.3.1 Total Insulin Syringe Market 43
3.3.1.1 Conventional Insulin Syringe Market 45
3.3.1.2 Safety Insulin Syringe Market 47
3.4 DRIVERS AND LIMITERS 49
3.4.1 Market Drivers 49
3.4.2 Market Limiters 49
3.5 COMPETITIVE MARKET SHARE ANALYSIS 53
ABBREVIATIONS 56
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023 3
Chart 3 1: Insulin Syringe Market by Segment, U.S., 2013 – 2023 41
Chart 3 2: Insulin Syringe Market Breakdown, U.S., 2016 42
Chart 3 3: Insulin Syringe Market Breakdown, U.S.,2023 42
Chart 3 4: Total Insulin Syringe Market, U.S., 2013 – 2023 44
Chart 3 5: Conventional Insulin Syringe Market, U.S., 2013 – 2023 46
Chart 3 6: Safety Insulin Syringe Market, U.S., 2013 – 2023 48
Chart 3 7: Leading Competitors, Insulin Syringe Market, U.S., 2016 55
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, U.S., 2016 6
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 7
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 8
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016 9
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 10
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2) 11
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2) 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016 27
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016 31
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016 32
Figure 3 1: Insulin Syringe Market by Segment, U.S., 2013 – 2023 (US$M) 40
Figure 3 2: Total Insulin Syringe Market, U.S., 2013 – 2023 43
Figure 3 3: Conventional Insulin Syringe Market, U.S., 2013 – 2023 45
Figure 3 4: Safety Insulin Syringe Market, U.S., 2013 – 2023 47
Figure 3 5: Drivers and Limiters, Insulin Syringe Market, U.S., 2016 52
Figure 3 6: Leading Competitors, Insulin Syringe Market, U.S., 2016 54
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
